Seeing is Believing: Visual Diagnostic Decision Support


By Art Papier

November 20, 2008 | Studies show that nearly 20 percent of all medical diagnoses and 60 percent of prescribed treatments are incorrect. Mistrust of the United States health care system and the economic impact of medical errors are considerable, creating less-than-optimal outcomes for patients and costing millions of health care dollars every year. Given that Medicare will no longer reimburse hospitals for errors deemed preventable, it is more critical than ever to avoid unnecessary errors.

Just as patients go online for health information, the Internet has also become a go-to diagnostic source for physicians. Physicians are replacing old, outdated reference books with software tools that provide up-to-date information for accurate diagnoses at the point of care. Whether suggesting a diagnosis or a treatment, these tools can be invaluable in reducing the number of diagnostic errors.

Given that half of all diseases present with a visual marker, and 10 to 20 percent of a general practitioner’s clinical diagnoses are visually based, visual diagnostic decision support (VDDS) can be a tremendous help to a physician in diagnosing an illness. The textbooks and atlases that the prior generation of physicians consulted often showed only classic or severe cases on fair-skinned individuals.

This is inadequate, as diseases present differently depending on the patient’s age and skin tone, the disease stage, and other factors, and can lead to a misdiagnosis. Unlike atlases, the VDDS is searchable by patient findings, which leads to a near immediate patient-relevant differential diagnosis, comprehensive medical images, and concise and regularly updated clinical information.

This transition to evidence-based visual diagnostic decision support is positively impacting the physician-patient relationship. With the VDDS system in place, patients perceive their physicians to be delivering higher-quality patient care and have more confidence in the diagnoses their physicians have concluded. Furthermore, when patients can see actual medical images that represent the diagnoses they are seeing on themselves, they have a greater sense of satisfaction and comfort in knowing they are not the “only one.”

By using professional resources not found freely on the Internet, physicians are instantly communicating to patients that they are taking the extra time to explore all possible diagnoses from a trusted source.

For example, consider the following: An adult female visits her primary care doctor with bilateral leg swelling, and her legs have been weeping for days. She is diagnosed with cellulitis and started on oral antibiotics. After a few days on the medication with no improvement, she is sent to the emergency department for admission for IV therapy for cellulitis.

The patient spends five days in the hospital with no significant improvement, and by this time, she has received eight days of total therapy and is experiencing increasing anxiety about her condition. A physician enters her signs and symptoms (findings: obesity, bilateral, leg, and weeping) into VDDS software, and a variety of conditions are presented and sorted by greatest relevance to the patient symptoms. A diagnosis of stasis dermatitis is identified and is validated with an image that looks extremely similar to the patient’s legs.

The VDDS system suggested that the physician consider an alternative diagnosis.  The system also delivered specialist-level treatment knowledge of the condition, and the patient was treated appropriately. With the appropriate therapy, the patient’s legs rapidly improved, and she was released from the hospital only two days later.

Complications of stasis dermatitis include infection and ulceration, and people suffering from venous diseases—particularly when the condition has been misdiagnosed—often experience depression and anxiety.

Using a VDDS provides physicians with early and accurate diagnosis, which can save time and money. Additionally, a VDDS can help avoid the administration of unnecessary antibiotics and improve outcomes for the patient, both physically and emotionally.

Art Papier, M.D. is CSO and founder of Logical Images, and an Associate Professor of Dermatology and Medical Informatics at the University of Rochester School of Medicine and Dentistry.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.